Phase 3 Trial Evaluates Retatrutide for Type 2 Diabetes and Weight Management
A new phase 3 trial shows that retatrutide significantly improves blood sugar control. The study also confirms notable weight…
-
-
Retatrutide Shows Sustained Weight Loss Benefits in Phase 3 TRIUMPH-1 Trial
The investigational triple hormone receptor agonist retatrutide targets GIP, GLP-1, and glucagon pathways. In the Phase 3 TRIUMPH-1 trial,…
-
Retatrutide: The Breakthrough Drug Changing Weight Loss
Obesity remains a clinically complex and treatment-resistant condition. Current pharmacological options like semaglutide and tirzepatide have advanced weight management….
